We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Preoperative Chemoradiotherapy With Gemcitabine for Resectable Pancreatic Carcinoma

This study is currently recruiting participants.
Verified September 2017 by Sang-Jae Park, National Cancer Center, Korea
Sponsor:
ClinicalTrials.gov Identifier:
NCT01333124
First Posted: April 11, 2011
Last Update Posted: September 14, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Sang-Jae Park, National Cancer Center, Korea
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)